Statement of Comprehensive Income

Comprehensive income is the change in equity (net assets) of a business enterprise during a period from transactions and other events and circumstances from non-owners sources. It includes all changes in equity during a period except those resulting from investments by owners and distributions to owners.

AstraZeneca PLC, consolidated statement of comprehensive income

US$ in millions

12 months ended:	Dec 31, 2014	Dec 31, 2013	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010
Profit for the period	1,235)	2,571)	6,327)	10,016)	8,081)
Remeasurement of the defined benefit pension liability	(766)	8)	(85)	(741)	(46)
Foreign exchange arising on consolidation	(823)	(166)	106)	(60)	26)
Foreign exchange arising on designating borrowings in net investment hedges	(529)	(58)	(46)	24)	101)
Fair value movements on derivatives designated in net investment hedges	100)	111)	76)	—)	—)
Amortisation of loss on cash flow hedge	1)	1)	1)	2)	1)
Net available for sale gains (losses) taken to equity	245)	69)	72)	31)	4)
Income tax relating to components of other comprehensive income	266)	(78)	(46)	198)	(61)
Other comprehensive income (loss) for the period, net of tax	(1,506)	(113)	78)	(546)	25)
Comprehensive income (loss) for the period	(271)	2,458)	6,405)	9,470)	8,106)
Comprehensive (income) loss attributable to non-controlling interests	5)	12)	(10)	(42)	(48)
Comprehensive income (loss) attributable to owners of the Parent	(266)	2,470)	6,395)	9,428)	8,058)

Based on: 20-F (reporting date: 2014-12-31), 20-F (reporting date: 2013-12-31), 20-F (reporting date: 2012-12-31), 20-F (reporting date: 2011-12-31), 20-F (reporting date: 2010-12-31).

Download chart

Comprehensive income item	Description	The company
Profit attributable to owners of the Parent	The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.	AstraZeneca PLC profit attributable to owners of the Parent decreased from 2012 to 2013 and from 2013 to 2014.
Comprehensive income (loss) attributable to owners of the Parent	Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Exclude changes in equity resulting from investments by owners and distributions to owners.	AstraZeneca PLC comprehensive income (loss) attributable to owners of the Parent decreased from 2012 to 2013 and from 2013 to 2014.

AstraZeneca PLC (NYSE:AZN)

Statement of Comprehensive Income